LARYNCLAVE 125/31 PD. FOR ORAL SUSP. 70ML

سعر LARYNCLAVE 125/31 PD. FOR ORAL SUSP. 70ML
0.00 جنية
الشركة المنتجة لـ LARYNCLAVE 125/31 PD. FOR ORAL SUSP. 70ML
MISR > AL ROWAD PHARMACEUTICAL INDUSTRIAL CO.
المادة الفعالة LARYNCLAVE 125/31 PD. FOR ORAL SUSP. 70ML
AMOXICILLIN+CLAVULANIC ACID
معلومات عن LARYNCLAVE 125/31 PD. FOR ORAL SUSP. 70ML
Amoxicillin is an analog of ampicillin derived from the basic penicillin nucleus 6-aminopenicillanic acid
Clavulanic acid is produced by the fermentation of Streptomyces clavuligerus. It is a beta-lactam structurally related to the penicillins and possesses the ability to inactivate some beta-lactamases by blocking the active sites of these enzymes.
Lower Respiratory Tract Infections � caused by beta-lactamase�producing isolates of Haemophilus influenzae and Moraxella catarrhalis.
Acute Bacterial Otitis Media � caused by beta-lactamase�producing isolates of H. influenzae and M. catarrhalis.
Sinusitis � caused by beta-lactamase�producing isolates of H. influenzae and M. catarrhalis.
Skin and Skin Structure Infections � caused by beta-lactamase�producing isolates of Staphylococcus aureus Escherichia coli and Klebsiella species.
Urinary Tract Infections � caused by beta-lactamase�producing isolates of E. coli Klebsiella species and Enterobacter species.